Recent FDA Health And Wellness Product Recalls
This article was originally published in The Rose Sheet
Executive Summary
Recalls reported by FDA for health and wellness products.
You may also be interested in...
GMP Problems Stop Canadian Firms’ Topical OTC, Homeopathic Imports
Homeolab USA’s and Cellex-C’s imports were stopped earlier in 2017 following GMP inspections at their facilities, and FDA warns that approvals for marketing of additional products in the US could be withheld until each firm is GMP-complaint. Homeolab trips up by trying to prevent FDA photography inside plant.
GMP Problems Stop Canadian Firms’ Topical OTC, Homeopathic Imports
Homeolab USA’s and Cellex-C’s imports were stopped earlier in 2017 following GMP inspections at their facilities, and FDA warns that approvals for marketing of additional products in the US could be withheld until each firm is GMP-complaint. Homeolab trips up by trying to prevent FDA photography inside plant.
Safecor Recalls Acetaminophen, Calcium Vitamin Following GMP Citations
Safecor Health's recalls, recently categorized as class II by FDA, began in July 2016, a month after FDA's Office of Regulatory Affairs cited GMP problems at the firm's Columbus, Ohio, facility.